Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
Bioorganic & Medicinal Chemistry|October 27, 2005
High-throughput screening of ecdysone agonists using a reporter gene assay followed by 3-D QSAR analysis of the molting hormonal activityCraig E Wheelock, Yoshiaki Nakagawa, Toshiyuki Harada, et al.
Cancer Science|June 26, 2003
Predictive value of expression of P53, Bcl-2 and lung resistance-related protein for response to chemotherapy in non-small cell lung cancersToshiyuki Harada, Shigeaki Ogura, Koichi Yamazaki, et al.
Lung Cancer (Amsterdam, Netherlands)|July 7, 2009
Clinical characteristics of pleomorphic carcinoma of the lungKenichiro Ito, Satoshi Oizumi, Shinichi Fukumoto, et al.
Respiration; International Review of Thoracic Diseases|September 17, 2002
Necrotizing sarcoid granulomatosis presenting with elevated serum soluble interleukin-2 receptor levelsToshiyuki Harada, Toraji Amano, Ayumu Takahashi, et al.
The Oncologist|June 20, 2020
Phase II Study of Low-Dose Afatinib Maintenance Treatment Among Patients with EGFR-Mutated Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1601 (NJLCG1601)Atsushi Nakamura, Hisashi Tanaka, Ryota Saito, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2017
Randomized Phase III and Extension Studies of Naldemedine in Patients With Opioid-Induced Constipation and CancerNobuyuki Katakami, Toshiyuki Harada, Toru Murata, et al.
Respirology Case Reports|October 3, 2022
IgG4 related lung disease mimicking multiple pleural disseminated lung cancerKoya Ito, Yukiko Maeda, Akane Mita, et al.
Cancer|October 5, 2002
Real-time tumor-tracking radiation therapy for lung carcinoma by the aid of insertion of a gold marker using bronchofiberscopyToshiyuki Harada, Hiroki Shirato, Shigeaki Ogura, et al.
International Journal of Clinical Oncology|March 8, 2025
High incidence of immune checkpoint inhibitor-induced pneumonitis in patients with non-small cell lung cancer and interstitial pneumonia, regardless of honeycomb lung or forced vital capacity: results from a multicenter retrospective studyYuriko Ishida, Satoshi Ikeda, Toshiyuki Harada, et al.
Thoracic Cancer|September 15, 2021
Phase I/II study of biweekly nab-paclitaxel in patients with platinum-pretreated non-small cell lung cancer: NJLCG1402Eisaku Miyauchi, Hisashi Tanaka, Atsushi Nakamura, et al.
Pageof 12